Pfizer Inc
PFE
Revenue
13.28B
▼-1.60B▼-10.73%
3 Months ChangeAssets
216.19B
▼-4.90B▼-2.22%
3 Months ChangeLiabilities
128.22B
▼-319.00M▼-0.2482%
3 Months ChangeFree Cash Flow
386.00M
▲313.00M▲428.77%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-29
Form 8-K
ID: 0000078003-24-000188
2024-10-15
Form 8-K
ID: 0000078003-24-000185
2024-08-05
Form 10-Q
ID: 0000078003-24-000166
2024-07-30
Form 8-K
ID: 0000078003-24-000155
2024-07-26
Form 8-K
ID: 0000078003-24-000144
2024-07-10
Form 8-K
ID: 0000078003-24-000130
2024-07-01
Form 8-K
ID: 0000078003-24-000127
2024-05-22
Form 8-K
ID: 0000078003-24-000113
2024-05-08
Form 10-Q
ID: 0000078003-24-000107
2024-05-01
Form 8-K
ID: 0000078003-24-000103